View more job listings or post a job
Chinook Therapeutics, Inc Sr. Scientist, In Vivo Pharmacology (Team Lead)
AbVision Senior/Principle Scientist (Immunology/Cell Biology)
Genentech, Inc. Associate Scientist, Biomarker Mass Spectrometry Laboratory  
Genentech, Inc. Senior Scientific Researcher for Biomarker Mass Spectrometry Laboratory
Genentech Inc. Contractor Scientist–Drug Metabolism
Genentech, Inc. Associate Scientist / Scientist, Biotransformation and ADME of New Modality  
Genentech, Inc. Scientist / Sr. Scientist, Drug Metabolism and Pharmacokinetics  
Pliant Therapeutics, Inc. Senior Research Associate, DMPK
STEMSourcing LLC DIrector Pharmacometrics
Global Blood Therapeutics SCIENTIST – DMPK
Post a job

Senior Scientist, DMPK/Clinical Pharmacology

Agios Pharmaceuticals


Agios Pharmaceuticals is searching for a dynamic Senior Scientist to join our growing DMPK/Clinical Pharmacology team.  The Senior Scientist will be responsible for working with various CROs for designing and analyzing in-vitro/in-vivo ADME studies and addressing issues related to metabolism and drug-drug interactions for both discovery and development programs. The ideal candidate will have a proven ability in identification of biotransformation pathways and metabolic enzymes/drug transporters involved in disposition of new therapeutic agents. A successful candidate should be able to exhibit strong communication and interpersonal skills and desire to work in a fast-paced, flexible and dynamic environment. 

Key Responsibilities

  1. Design and execute in vitro and in vivo (preclinical and clinical) drug metabolism/ADME studies in support of discovery and development programs
  2. Metabolic soft-spot identification and assessment reactive pathways to guide medicinal chemistry efforts in lead discovery and optimization
  3. Elucidate biotransformation pathways and determine the role of metabolic enzymes (CYP & non-CYPs) and drug transporters involved in the disposition of new chemical entities
  4. Identification of drug interaction liabilities due to enzyme/transporter substrate/inhibition/induction and set-up exclusion criteria in first-in-human trials
  5. Provides leadership in clinical DDI study design based on clearance pathways, phenotyping and alteration of metabolic enzymes/drug-transporters activity
  6. Serve as a subject matter expert in drug metabolism and DDIs with in DMPK/Clinical Pharmacology
  7. Contribute for drafting INDs, IBs, briefing books and NDA documents to support regulatory submissions


Minimum Requirements

  • Applicants should possess a PhD or Masters in Organic Chemistry/Medicinal Chemistry /Pharmaceutical Sciences with 5+ (PhD) or 8+ years (Masters) of pharmaceutical industry experience
  • Good understanding of organic chemistry principles/structural elucidation of small molecules and xenobiotic metabolism is required
  • The candidate should have extensive experience interpreting mass spectral (LC-MS) data and other structural elucidation techniques such as NMR, chemical derivatization etc.
  • Strong knowledge in clinical relevance of clearance mechanisms and role of enzymes (CYPs & non-CYPs) and transporters in drug metabolism is required
  • Thorough understanding of metabolism and DDI regulatory guidelines is an asset
  • Ability to work independently with a minimum supervision, design experiments and report data in written reports and team presentations as required
  • The individual is also expected to be highly organized, a team player, enthusiastic about drug discovery, and possess strong communication and collaborative skills

Preferred Qualifications

  • Experience in conducting radio-labeled ADME studies is preferred
  • Hands-on experience in translational PBPK modeling to predict pharmacokinetic based drug interactions is highly desirable
  • Publications in peer-reviewed scientific journals is desirable


Location: Cambridge, MA


Post Date: 1/22/2020 12:00:00 AM
┬ęPharmaceutical & BioScience Society, International; Last Modified: 5/29/2020; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Ltd. Experts in scalable synthesis & purification of drug metabolites, including CYP, AOX, FMO metabolites as well as O-, N-, acyl glucuronides & sulfates.
Submit a Text Ad